ID | 1503 | |
PMID | 15603887 | |
Year | 2005 | |
Sequence | SKYALVDASLKMADP NRFRGKDLPVLDQL | |
Name | gD 1-29 (group 1) | |
Length | 29 | |
N-Terminal Modification | Free | |
C-Terminal Modification | Free | |
Linear/ Cyclic | Linear | |
Chirality | L | |
Chemical Modification | None | |
Origin of Peptide | T-cell epitope peptide identified from HSV1-gD | |
Nature of Peptide/Cargo | not mentioned | |
Mechanism | T-cell epitope peptide identified from HSV1-gD | |
Cargo Sequence/Structure | None | |
Name of cargo | Not applicable | |
Assay | ELISA, Antibody assay, Peptide specific T-cell assays | |
Enhancer | PBS (pH 7.3). | |
Properties of enhancer | Not mentioned | |
Concentration | 25ul | |
Incubation time | 21 days | |
Tissue permeability (value with units) | Failed to induce significant IgA titers (p > 1). | |
Tissue Sample | eye | |
Ex vivo/In vivo/In vitro | in vivo | |
STRUCTURE |
| |
SMILES | N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C (=O)N[C@H](C(=O)N[C@H]([C@H](O)N[C@H](C(=O)N[C@H]([C@@H] 1OO[C@@H]([C@@H](NC(=O)CNC(=O)[C@@H](N[C@@H]2 [C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]3N(C(=O) [C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O) [C@@H](NC(=O)[C@@H](N1)CO)CC(C)C)CCCCN)CCSC)C) CC(=O)O)CCC3)CC(=O)N)CCCNC(=N)N)Cc1ccccc1O2) CCCNC(=N)N)CCCCN)N[C@H](C(=O)N[C@H](C(=O)N1 [C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H] (C(=O)N[C@H](C(=O)N[C@H](C=O)CC(C)C)CCC(=O)N)CC(=O)O) CC(C)C)C(C)C)CCC1)CC(C)C)CC(=O)O)C)CC(=O)O) C(C)C)CC(C)C)C)Cc1ccc(cc1)O)CCCCN)CO |